AGL 37.40 Decreased By ▼ -0.60 (-1.58%)
AIRLINK 216.70 Increased By ▲ 2.79 (1.3%)
BOP 9.48 Increased By ▲ 0.06 (0.64%)
CNERGY 6.63 Increased By ▲ 0.34 (5.41%)
DCL 8.71 Decreased By ▼ -0.06 (-0.68%)
DFML 42.90 Increased By ▲ 0.69 (1.63%)
DGKC 94.95 Increased By ▲ 0.83 (0.88%)
FCCL 35.50 Increased By ▲ 0.31 (0.88%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 17.78 Increased By ▲ 1.39 (8.48%)
HUBC 127.75 Increased By ▲ 0.85 (0.67%)
HUMNL 13.75 Increased By ▲ 0.38 (2.84%)
KEL 5.34 Increased By ▲ 0.03 (0.56%)
KOSM 6.90 Decreased By ▼ -0.04 (-0.58%)
MLCF 43.50 Increased By ▲ 0.52 (1.21%)
NBP 59.58 Increased By ▲ 0.73 (1.24%)
OGDC 222.50 Increased By ▲ 3.08 (1.4%)
PAEL 39.80 Increased By ▲ 0.64 (1.63%)
PIBTL 8.25 Increased By ▲ 0.07 (0.86%)
PPL 195.29 Increased By ▲ 3.63 (1.89%)
PRL 38.90 Increased By ▲ 0.98 (2.58%)
PTC 27.46 Increased By ▲ 1.12 (4.25%)
SEARL 104.80 Increased By ▲ 0.80 (0.77%)
TELE 8.56 Increased By ▲ 0.17 (2.03%)
TOMCL 34.80 Increased By ▲ 0.05 (0.14%)
TPLP 13.05 Increased By ▲ 0.17 (1.32%)
TREET 25.50 Increased By ▲ 0.16 (0.63%)
TRG 73.12 Increased By ▲ 2.67 (3.79%)
UNITY 33.20 Decreased By ▼ -0.19 (-0.57%)
WTL 1.71 Decreased By ▼ -0.01 (-0.58%)
BR100 11,990 Increased By 95.9 (0.81%)
BR30 37,326 Increased By 470.8 (1.28%)
KSE100 111,464 Increased By 1040.3 (0.94%)
KSE30 35,064 Increased By 285.9 (0.82%)

LAHORE: Opening batsman Imam-ul-Haq has been ruled out of the home Test series against South Africa due to a thumb fracture.

Imam (25), who sustained the injury during tour to New Zealand underwent scans which revealed he has yet to make a full recovery.

Imam said doctors have advised him rest for another one and a half week. "I have been barred from even taking part in practice sessions," he added. Pakistan is set to host South Africa for two Test matches. The series opener will be contested in Karachi from January 26 while Rawalpindi will host the second Test starting from February 4. Chief Selector Wasim said the 20-member squad for the fixtures will be announced on Friday.

Copyright Business Recorder, 2021

Comments

Comments are closed.